Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin K for Cefoperazone/Sulbactam Induced Coagulopathy
NCT05742295Phase 4Completed
- Sponsor
- Helwan University
- Start
- Feb 2023
- Primary completion
- Oct 2023
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of phytomenadione in coagulopathy, sponsored by Helwan University. Started Feb 2023; status: completed.
02
Drugs
phytomenadione
03
Conditions
coagulopathy
Beyond the preview
Go deeper on NCT05742295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05742295.